Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials
JAMA Oncol
.
2019 Apr 1;5(4):457-458.
doi: 10.1001/jamaoncol.2018.6205.
Authors
Jessica K Roydhouse
1
,
Mallorie H Fiero
2
,
Paul G Kluetz
3
Affiliations
1
Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
2
Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
3
Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland.
PMID:
30653227
DOI:
10.1001/jamaoncol.2018.6205
No abstract available
MeSH terms
Bias
Clinical Trials as Topic*
Humans
Neoplasms / drug therapy*
Patient Reported Outcome Measures*